| Date | Title | | 07/28/10 | New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study| First Autologous Cellular Immunotherapy to Prolong Survival in Cancer -
SEATTLE, July 28, 2010 /PRNewswire via COMTEX/ -- Dendreon Corporation (Nasdaq: DNDN) announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE(R) (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostat... |
| | 07/12/10 | Dendreon to Host Conference Call on August 3rd to Announce Second Quarter Financial Results| SEATTLE, July 12, 2010 /PRNewswire via COMTEX/ --Dendreon Corporation (Nasdaq: DNDN) management will host a conference call on Tuesday, August 3, 2010 at 4:30 p.m. ET to review second quarter financial results. Access to the discussion may be obtained as follows:
Time: 4:30 PM ET / 1:30 PM PT
Date: August 3, 2010
1-800-901-5247 (domestic) or +1-617-786-4501
Dial-in: (international);
conference pass code: 32238437
... |
| | 06/30/10 | Dendreon Statement on CMS National Coverage Analysis| SEATTLE, June 30, 2010 /PRNewswire via COMTEX/ --Dendreon Corporation (Nasdaq: DNDN) announced that the Centers for Medicare and Medicaid Services (CMS) today initiated a National Coverage Analysis (NCA) of PROVENGE(R) (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). PROVENGE is the first in a new therapeutic class known as autologous cellular immunotherapies... |
| | 06/08/10 | Dendreon Announces Webcast Presentations at Upcoming Investor Conferences| SEATTLE, June 8, 2010 /PRNewswire via COMTEX/ --Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following investor conferences in June:
Jefferies 2010 Global Life Sciences Conference, New York, NY
June 8, 2010
4:00 p.m. ET
Needham 9th Annual Health Care Conference, New York, NY
June 9, 2010
4:00 p.m. ET
Goldman Sachs 31st Annual Global Healthcare Conference, Los Angeles, CA
June 16, 2010
6:20 p.m. ET
NASDAQ OMX 24th Investor Program, London,... |
|
|
